Ex vivo approach to treat failing organs: Expanding the limits

European Surgical Research

Volumn 54, Issue 1-2, 2015, Pages 64-74

  Ciubotaru, Anatol ^a,b   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

Author keywords

Autotransplantation; Ex vivo organ perfusion; Ex vivo organ preservation; Ex vivo organ treatment

Indexed keywords

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER SURGERY; CELL THERAPY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; CONVALESCENCE; CRYOPRESERVATION; DIAGNOSTIC PROCEDURE; EX VIVO STUDY; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; ISOLATED ORGAN; KIDNEY TRANSPLANTATION; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG RESECTION; LUNG TRANSPLANTATION; MEDLINE; MICROCLIMATE; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; ORGAN DONOR; ORGAN PERFUSION; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; ANIMAL; PERFUSION;

ANIMALS; HUMANS; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PERFUSION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84927795192     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000367942     Document Type: Review

References (55)

1. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, Roberts JP. Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-The-Art Winter Symposium. Am J Transplant 2008; 8: 745-752.
2. Watson CJ, Dark JH. Organ transplantation: historical perspective and current practice. Br J Anaesth 2012; 108(suppl 1): i29-i42.
3. Diaz-Guzman E, Hoopes CW, Zwischenberger JB. The evolution of extracorporeal life support as a bridge to lung transplantation. ASAIO J 2013; 59: 3-10.
4. Fuehner T, Kuehn C, Hadem J, Wiesner O, Gottlieb J, Tudorache I, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185: 763-768.
5. Olsson KM, Simon A, Strueber M, Hadem J, Wiesner O, Gottlieb J, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010; 10: 2173-2178.
6. Van Raemdonck D, Neyrinck A, Rega F, Devos T, Pirenne J. Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells?. Curr Opin Organ Transplant 2013; 18: 24-33.
7. Sanchez PG, Bittle GJ, Burdorf L, Pierson RN 3rd, Griffith BP. State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions. J Heart Lung Transplant 2012; 31: 339-348.
8. Souilamas R, Souilamas JI Jr, Saueressig M, Briot R. Advanced normothermic ex vivo lung maintenance using the mobile Organ Care System. J Heart Lung Transplant 2011; 30: 847-848.
9. Monbaliu D, Brassil J. Machine perfusion of the liver: past, present and future. Curr Opin Organ Transplant 2010; 15: 160-166.
10. Ingemansson R, Eyjolfsson A, Mared L, Pierre L, Algotsson L, Ekmehag B, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87: 255-260.
11. Aigner C, Slama A, Hotzenecker K, Scheed A, Urbanek B, Schmid W, et al. Clinical ex vivo lung perfusion -pushing the limits. Am J Transplant 2012; 12: 1839-1847.
12. Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S. Ex-vivo lung perfusion. Transpl Int 2014, Epub ahead of print
13. Van Raemdonck D. Thoracic organs: current preservation technology and future prospects; part 1: lung. Curr Opin Organ Transplant 2010; 15: 150-155.
14. Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjoberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76: 244-252; discussion 52.
15. Warnecke G, Moradiellos J, Tudorache I, Kuhn C, Avsar M, Wiegmann B, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet 2012; 380: 1851-1858.
16. Collins MJ, Moainie SL, Griffith BP, Poston RS. Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool. Eur J Cardiothorac Surg 2008; 34: 318-325.
17. Ozeki T, Kwon MH, Gu J, Collins MJ, Brassil JM, Miller MB Jr, et al. Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. Circ J 2007; 71: 153-159.
18. Rosenbaum DH, Peltz M, DiMaio JM, Meyer DM, Wait MA, Merritt ME, et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. J Heart Lung Transplant 2008; 27: 93-99.
19. Ghodsizad A, Bordel V, Ungerer M, Karck M, Bekeredjian R, Ruhparwar A. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum 2012; 15: E161-E163.
20. Starzl TE, Groth CG, Brettschneider L, Moon JB, Fulginiti VA, Cotton EK, et al. Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery 1968; 63: 549-563.
21. Franco-Gou R, Mosbah IB, Serafin A, Abdennebi HB, Rosello-Catafau J, Peralta C. New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. J Gastroenterol Hepatol 2007; 22: 1120-1126.
22. Hessheimer AJ, Fondevila C, Garcia-Valdecasas JC. Extracorporeal machine liver perfusion: are we warming up?. Curr Opin Organ Transplant 2012; 17: 143-147.
23. Vogel T, Brockmann JG, Friend PJ. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant 2010; 15: 167-172.
24. Moers C, Smits JM, Maathuis MH, Treckmann J, Van Gelder F, Napieralski BP, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
25. Nicholson ML, Hosgood SA, Metcalfe MS, Waller JR, Brook NR. A comparison of renal preservation by cold storage and machine perfusion using a porcine autotransplant model. Transplantation 2004; 78: 333-337.
26. Brook NR, Waller JR, Nicholson ML. Nonheart-beating kidney donation: current practice and future developments. Kidney Int 2003; 63: 1516-1529.
27. Schilling M, Saunder A, Southard JH, Belzer FO. Long-Term renal preservation and prevention of acute tubular necrosis by inhibition of arachidonate metabolism. Swiss Surg 1995; 4: 205-209.
28. Polyak MM, Arrington BO, Kapur S, Stubenbord WT, Kinkhabwala M. Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function. Transplantation 2000; 69: 184-186.
29. Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesch P, Bretschneider HJ. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg 1990; 77: 21-26.
30. Gallagher KA, Phelan MW, Stern T, Bartlett ST. Repair of complex renal artery aneurysms by laparoscopic nephrectomy with ex vivo repair and autotransplantation. J Vasc Surg 2008; 48: 1408-1413.
31. Morin J, Chavent B, Duprey A, Albertini JN, Favre JP, Barral X. Early and late results of ex vivo repair and autotransplantation in solitary kidneys. Eur J Vasc Endovasc Surg 2012; 43: 716-720.
32. Pichlmayr R, Bretschneider HJ, Kirchner E, Ringe B, Lamesch P, Gubernatis G, et al. Ex situ operation on the liver. A new possibility in liver surgery. Langenbecks Arch Chir 1988; 373: 122-126.
33. Miura K, Sato Y, Kokai H, Hara Y, Kobayashi T, Oya H, et al. Liver transplantation surgical techniques for extensive retroperitoneal tumor with major blood vessel involvement: a case report. Transplant Proc 2012; 44: 579-580.
34. Wen H, Dong JH, Zhang JH, Zhao JM, Shao YM, Duan WD, et al. Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis. Chin Med J 2011; 124: 2813-2817.
35. Tzakis AG, Pararas NB, Tekin A, Gonzalez-Pinto I, Levi D, Nishida S, et al. Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: long-Term follow-up. Surgery 2012; 152: 82-89.
36. Clark DA, Quint RA, Mitchell RL, Angell WW. Coronary artery spasm. Medical management, surgical denervation, and autotransplantation. J Thorac Cardiovasc Surg 1977; 73: 332-339.
37. Bertrand ME, Lablanche JM, Tilmant PY, Ducloux G, Warembourg H Jr, Soots G. Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol 1981; 47: 1375-1378.
38. Cooley DA, Reardon MJ, Frazier OH, Angelini P. Human cardiac explantation and autotransplantation: application in a patient with a large cardiac pheochromocytoma. Tex Heart Inst J 1985; 12: 171-176.
39. Reardon MJ, DeFelice CA, Sheinbaum R, Baldwin JC. Cardiac autotransplant for surgical treatment of a malignant neoplasm. Ann Thorac Surg 1999; 67: 1793-1795.
40. Conklin LD, Reardon MJ. Autotransplantation of the heart for primary cardiac malignancy: development and surgical technique. Tex Heart Inst J 2002; 29: 105-108; discussion 108.
41. Blackmon SH, Patel AR, Bruckner BA, Beyer EA, Rice DC, Vaporciyan AA, et al. Cardiac autotransplantation for malignant or complex primary left-heart tumors. Tex Heart Inst J 2008; 35: 296-300.
42. Kallenbach K, Cremer J, Haverich A. Partial ex situ surgery of the heart. J Thorac Cardiovasc Surg 2002; 123: 577-578.
43. Kallenbach K, Haverich A. Explantation of the heart for resection of primary cardiac tumors can be avoided by partial ex situ heart surgery. Thorac Cardiovasc Surg 2003; 51: 293-294.
44. Zhang G, Li M, Yan G, Liu J, Jiang G. Lung autotransplantation technique in the treatment of stage III bronchogenic carcinoma (in Chinese). Zhonghua Wai Ke Za Zhi 1998; 36: 158-160.
45. Hendrix H, Schmitt J, Aebert H. Ex situ sleeve resection and autotransplantation of the left lower pulmonary lobe after extended pneumonectomy (in German). Chirurg 2000; 71: 820-823.
46. Kruger M, Zinne N, Hoffler H, Zhang R, Kropivnitskaja I, Schmitto J, et al. Ex situ tracheobronchoplastic operations using the organ care system (in German). Chirurg 2013; 84: 208-213.
47. Schroder C, Fisher S, Pieck AC, Muller A, Jaehde U, Kirchner H, et al. Technique and results of hyperthermic (41 degrees C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis. Eur J Cardiothorac Surg 2002; 22: 41-46.
48. Krementz ET. Lucy Wortham James lecture. Regional perfusion. Current sophistication, what next?. Cancer 1986; 57: 416-432.
49. Johnston MR, Christensen CW, Minchin RF, Rickaby DA, Linehan JH, Schuller HM, et al. Isolated total lung perfusion as a means to deliver organ-specific chemotherapy: long-Term studies in animals. Surgery 1985; 98: 35-44.
50. Putnam Jr. JB. New and evolving treatment methods for pulmonary metastases. Semin Thorac Cardiovasc Surg 2002; 14: 49-56.
51. Grootenboers MJ, Schramel FM, Van Boven WJ, Van Putte BP, Hendriks JM, Van Schil PE. Re-evaluation of toxicity and long-Term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial. Ann Thorac Surg 2007; 83: 1235-1236.
52. Van Schil PE, Hendriks JM, Van Putte BP, Stockman BA, Lauwers PR, Ten Broecke PW, et al. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases. Eur J Cardiothorac Surg 2008; 33: 487-496.
53. Cypel M, Keshavjee S. The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med 2012; 6: 27-35.
54. Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1: 4ra9.
55. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106: 16357-16362.